R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for ... Monthly Prescribing Reference SAN DIEGO, CA—The rituximab, bendamustine, and cytarabine (R-BAC) chemotherapy regimen was shown to be effective in previously untreated patients >65 years old with mantle cell lymphoma (MCL), as well as in patients who are relapsed or refractory (R/R ... |
